Johnson & Johnson (UKEX:JNJ)
â‚´ 5947 0 (0%) Market Cap: 14.82 Til Enterprise Value: 15.47 Til PE Ratio: 24.01 PB Ratio: 4.98 GF Score: 84/100

Johnson & Johnson at TD Cowen Health Care Conference Transcript

Mar 04, 2024 / 04:10PM GMT
Release Date Price: â‚´5947
Joshua Thomas Jennings
TD Cowen, Research Division - MD & Senior Research Analyst

Fireside chat session. We are thrilled to be moving down the medical devices track with executive from Johnson & Johnson's MedTech business unit. We have Hani Abouhalka, Company Group Chairman, Robotics and Digital, Johnson & Johnson MedTech. Hani, thanks so much for joining us today at the 44th Annual TD Cowen Healthcare Conference. Thanks to the J&J team for joining as well, the IR team.

Questions & Answers

Joshua Thomas Jennings
TD Cowen, Research Division - MD & Senior Research Analyst

I'd love to just get -- start off from a high level. You've been at Johnson & Johnson for 20-plus years. You have had experience across most divisions within the J&J MedTech business. There's the 2019 acquisitions of Auris and Verily, the Verily stake of Verb Surgical. A lot of internal efforts. You guys have been delivering the OTTAVA soft tissue robot program.

But I guess the initial question is just, from a high level, where do the Johnson

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot